http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View More Recent Stories
-
International Stem Cell Corporation Announces Successful Cell Transplantation for the First Patient in Phase 1 Clinical Trial of ISC-hpNSC
-
International Stem Cell Corporation Announces Publication of Preclinical Results Demonstrating Treatment of Parkinson's Disease in Cell Transplantation
-
International Stem Cell Corporation Announces Operating Results for the Three-Months Ended March 31, 2016
-
International Stem Cell Corporation Announces 2015 Fourth Quarter and Year-End Results
-
International Stem Cell Corporation to Raise $6.3 Million Through a Private Placement to Fund Phase I Clinical Trial
-
International Stem Cell Corporation Announces Commencement of Enrollment of Phase I Trial of ISC-hpNSC
-
International Stem Cell Corporation Signed a Clinical Service Agreement With the Florey Institute of Neuroscience and Mental Health
-
International Stem Cell Corporation Receives Authorization to Initiate Phase I/IIa Clinical Trial of ISC-hpNSC for the Treatment of Parkinson's Disease
-
International Stem Cell Corporation Announces Operating Results for the Three- and Nine-Months Ended September 30, 2015
-
International Stem Cell Corporation Moves Forward With Parkinson's Disease Clinical Trials in Australia
-
International Stem Cell Corporation Presents Comprehensive Findings for Parkinson's Disease Program Preclinical Studies at the Society for Neuroscience Annual Meeting, Neuroscience 2015
-
International Stem Cell Corporation Develops Technology to Replace Cartilage for the Treatment of Osteoarthritis
-
International Stem Cell Names Ms. Ebrahimi as Chief Financial Officer
-
International Stem Cell Corporation Announces Next Phase of Research Collaboration With Rohto Pharmaceutical Co., Ltd. of Japan
-
International Stem Cell Corporation to Present at the Rodman and Renshaw Global Investment Conference
-
International Stem Cell Corporation Announces 2015 First Quarter Results
-
International Stem Cell Corporation Demonstrates Reversal of Neurological Stroke Symptoms Using Neural Stem Cells
-
International Stem Cell Corporation Announces 2014 Fourth Quarter and Year-End Results
-
International Stem Cell Corporation Receives Key Stem Cell Patent in Japan

